Annemilaï Tijeras-Raballand
Director of Preclinical and Translational Research at Onward Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
French Native or bilingual proficiency
-
German Native or bilingual proficiency
-
English Full professional proficiency
Topline Score
Bio
Experience
-
Onward Therapeutics
-
Switzerland
-
Biotechnology Research
-
1 - 100 Employee
-
Director of Preclinical and Translational Research
-
Dec 2020 - Present
-
-
-
AFR Oncology
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
CEO and Head of the preclinical and translational Laboratory
-
Mar 2017 - Nov 2020
- Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical) - Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical)
-
-
-
-
Head of the preclinical and translationnal Laboratory
-
Sep 2014 - Feb 2017
- Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical) - Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical)
-
-
-
-
Project Manager
-
Jul 2011 - Sep 2014
- Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical) - Translational research - New drugs development - Drugs repositioning - CRO activities (pre-clinical & clinical)
-
-
-
-
PhD student
-
Oct 2007 - Nov 2010
-
-
Graduate Student
-
Apr 2006 - Sep 2007
-
-
Education
-
Greta Val de Loire
Niveau I expérimentation animale, Animal Behavior and Ethology -
Université Denis Diderot (Paris VII) / University Paris VII
Doctor of Philosophy (Ph.D.), Callular Biology, Physiology and Pathology -
Université Denis Diderot (Paris VII) / University Paris VII
Master's degree, Cellular Biology, Physiology and Pathology